Fintech's cGMP plant will be put into use soon. the plant is around 50,000sqm, includes 4 multi-purpose plants, 1 hydrogenation plant, 100,000 class clean room, 1 6000sqm R&D building. the whole plant is disigned under cGMP guildline,provide RSM and pre-clinical API 's R&D and production service.

We will be CPHI Shanghai during 16th-18th Dec., our booth no. is E2D79.

Welcome Gilead audit our plant,and thanks for the precious suggestion. "From innovation to commercialization,Finetech accelerate your vision" We will continously provide quality,cost effective and stable supply to all customers under regulation.
 

Finetech Chemical got patents about synthesis of baloxavir intermediates. 
From Innovation To Commercialization, Finetech Chemcial Helps Accelerate Your Vision

Fintech Chemical got the patent of Indacaterol intermediate

5-(Chloroacetyl)-8-(phenylmethoxy)-2(1H)-quinolinone

Finetech passes the auditation of CR Double-Crane

Baloxavir intermediates has entered into the pilot production stage